4 completed, 3 recruiting, 1 active not recruiting, 1 not yet recruiting. 6 Phase 1, 2 Phase 4, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Active not recruiting 1, Recruiting 1 |
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Recruiting 1 |
Follow Itraconazole (200 mg): new trials by email Literature Review of Itraconazole (200 mg) trials Research Report on Itraconazole (200 mg)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11 TBD11 (300 mg), Placebo, Itraconazole (200 mg) - Healthy Adult Participants | Phase 1 | Recruiting | Gates Medical Research Institute | 66 | 2026-10-21 | 2026-10-22 |
| Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail Itraconazole (200 mg), ISOtretinoin 20 MG - Tinea Corporis | Phase 4 | Not yet recruiting | Pak Emirates Military Hospital | 60 | 2026-10-01 | 2026-06-30 |
| A Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult Participants Radiprodil, Carbamazepine, Itraconazole (200 mg) - Healthy Adult Participants | Phase 1 | Active not recruiting | GRIN Therapeutics, Inc. | 36 | 2026-06-08 | 2026-10-21 |
| The Effectiveness of Itraconazole Pulse Therapy vs Topical 2% Ketoconazole in the Treatment of Moderate to Severe Seborrheic Dermatitis of Scalp. Itraconazole (200 mg), Ketoconazole 2% - Seborrheic Dermatitis | Early Phase 1 | Recruiting | Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan | 80 | 2026-01-07 | 2026-07-29 |
| Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis Itraconazole (200 mg), Fluconazole 150 mg - Tinea Corporis, Dermatophytosis | Phase 4 | Recruiting | Urooj Fatima | 126 | 2025-11-01 | 2026-01-15 |
| A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants varegacestat, Itraconazole (200 mg) - Healthy Volunteer | Phase 1 | Completed | Immunome, Inc. | 22 | 2024-11-11 | 2025-05-11 |
| Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers ZE50-0134 or placebo, Rabeprazole 20 mg, Itraconazole (200 mg) - Healthy | Phase 1 | Completed | Lomond Therapeutics Holdings, Inc. | 104 | 2024-05-21 | 2025-12-05 |
| Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers ZE46-0134 or placebo, Rabeprazole, 20mg oral, Itraconazole (200 mg) - AML | Phase 1 | Completed | Lomond Therapeutics Holdings, Inc. | 112 | 2023-07-28 | 2025-12-09 |
| Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women Lu AF35700, Itraconazole (200 mg), Itraconazole (300 mg) - Cytochrome P450 Interaction | Phase 1 | Completed | H. Lundbeck A/S | 22 | 2017-03-28 | 2019-10-02 |
Tinea (2) · Dermatitis, Seborrheic (1) · Leukemia, B-Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1)
Lomond Therapeutics Holdings, Inc. (2) · Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan (1) · GRIN Therapeutics, Inc. (1) · Gates Medical Research Institute (1) · H. Lundbeck A/S (1) · Immunome, Inc. (1) · Pak Emirates Military Hospital (1) · Urooj Fatima (1)
Pakistan (3) · United States (3) · Australia (2) · South Africa (1) · United Kingdom (1)
Michelle Valentine (1) · Urooj Fatima, MBBS (1)
2016 (1)